IFN signaling has also been assessed in peripheral blood lymphocytes (including total, naïve and effector memory T cells, B cells, and NK cells) from patients with breast cancer, melanoma, and gastrointestinal cancer via RT-qPCR, phosphoflow cytometry, and functional assays [18]. This evidence concerns the gene IFNA1 and breast carcinoma.